Stereotaxis Inc. is an American publicly traded corporation based in St. Louis, MO, that makes robotic products to improve the clinical outcomes of electrophysiology studies. The most notable of Stereotaxis’ products is the NIOBE® ES Remote Magnetic Navigation (RMN) System.With the first iterations of the RMN system originally designed for applications within the brain, its current usage is guiding magnetic catheters during electrophysiology studies and catheter ablation procedures to treat arrhythmias within in the heart. The technology has been approved by regulatory agencies in the United States, European Union and other countries around the world. Systems operate within cardiac catheter labs in hospitals and have been utilized in over 100,000 procedures worldwide as of 2017. In January 2022, Stereotaxis announced that the Fuwai Central China Cardiovascular Hospital has become the first in central China to establish a robotic electrophysiology program with the company's robotic magnetic navigation technology.